Related Experiment Video

Updated: Jan 16, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

676

Sustained PSA screening is associated with downstaging and improved survival in prostate cancer: a 12-year Korean

Jung Kwon Kim1, Min Uk Park2, Donghyun Lee2

  • 1Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. andss1@hanmail.net.

BMC Cancer
|October 1, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Prostate cancerProstate-specific antigenScreeningStage migrationSurvival

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.0K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.1K

Related Experiment Videos

Last Updated: Jan 16, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

676
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.0K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.1K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648

Articles linked to this work by shared authors, journal, and citation graph.

Regression of retinal capillary hemangioblastoma with systemic belzutifan in von Hippel-Lindau disease: a case report.

Frontiers in oncology·2026

Tumoricidal efficacy of DZ-1 dye conjugated to dihydroartemisinin in patient-derived colorectal liver metastasis tumoroids.

Molecular therapy. Oncology·2026

Oncologic outcomes and renal function preservation after stereotactic ablative body radiotherapy versus radiofrequency ablation in stage I renal cell carcinoma.

Clinical and translational radiation oncology·2026

Linker-dependent variations in the tumoricidal activity of DZ-1-dihydroartemisinin conjugate formats.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Human Turbinate Mesenchymal Stromal Cell-Derived Exosomes Alleviate PM2.5-Induced Pyroptosis via Promoting Mitophagy in Human Vocal Fold Fibroblasts.

Journal of voice : official journal of the Voice Foundation·2026

3D surgical navigation contributes to renal function preservation during robot-assisted partial nephrectomy.

Journal of robotic surgery·2026

Family-centred psycho-oncological counselling for parents with cancer: a longitudinal secondary data analysis of psychological distress, family functioning and parental concerns.

BMC cancer·2026

Multi-omics profiling reveals sphingolipid metabolism reprogramming of tumor-conditioned MDSCs in cervical cancer.

BMC cancer·2026

Polygenic risk scores, adiposity, and disease transition in type 2 diabetes and colorectal cancer comorbidity: a population-based Chinese cohort study.

BMC cancer·2026

Profiling proteomic responses in small intestinal neuroendocrine tumor GOT1 after [177Lu]Lu-DOTATATE therapy.

BMC cancer·2026

Beyond CA-125: circulating cell-free DNA as the next-generation biomarker in ovarian malignancy.

BMC cancer·2026

NNMT-associated metabolic-thromboinflammatory-immune co-activation in heterogeneous CTC clusters: a hypothesis-generating computational framework".

BMC cancer·2026

Community-Based Prevention: Findings From Nearly 3 Decades of the Drug-Free Communities Support Program.

Journal of public health management and practice : JPHMP·2026

Empowering women through teach-back education: A protection motivation theory approach to breast cancer prevention in Northwest Iran.

Women's health (London, England)·2026

Integrating World Health Organization Package of Essential Noncommunicable Disease Interventions at Primary Health Care - An Impact Evaluation Study from a Mountainous State of India.

International journal of preventive medicine·2026

Insights from strengthening perinatal hepatitis b prevention in healthcare facilities in Delta State, Nigeria: A prospective, pilot implementation intervention.

Sage open chronic disease·2026

Elimination of HPV-associated cancers: universal HPV vaccination and the role of anal screening - a meeting report.

BMC proceedings·2026

Precision Prevention for Health: The Global Alliance Framework for the Promotion of Physical Activity.

Sports medicine (Auckland, N.Z.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us